Definitive Healthcare/$DH

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Definitive Healthcare

Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.

Ticker

$DH
Primary listing

Industry

Health Care Technology

Employees

782

ISIN

US24477E1038

DH Metrics

BasicAdvanced
$433M
-
-$4.42
1.64
-

What the Analysts think about DH

Analyst ratings (Buy, Hold, Sell) for Definitive Healthcare stock.

Bulls say / Bears say

Definitive Healthcare launched Market Forecast, a predictive analytics solution offering three, five, and ten-year market trend projections, enhancing strategic planning for healthcare organizations. (globenewswire.com)
Irenic Capital Management LP significantly increased its investment in Definitive Healthcare by acquiring 6,413,185 shares at $4.47 per share, indicating strong institutional confidence. (gurufocus.com)
BTIG initiated coverage of Definitive Healthcare with a 'Buy' rating and a $7.00 price target, highlighting the company's comprehensive data collection and analytics platform supporting various healthcare sectors. (investing.com)
Morgan Stanley downgraded Definitive Healthcare's stock rating from 'Overweight' to 'Equalweight' and reduced the price target to $9.00, citing a slowdown in year-over-year revenue growth projections for 2024. (investing.com)
The company's stock reached a 52-week low of $2.31, reflecting a significant 69.21% decline over the past year, raising concerns about its market performance. (investing.com)
Definitive Healthcare reported a challenging Q4 2024, with earnings per share significantly missing expectations at -$0.51 compared to the projected $0.07, and a 6% year-over-year revenue decline. (investing.com)
Data summarised monthly by Lightyear AI. Last updated on 8 Jul 2025.

DH Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

DH Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $DH

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs